Daridorexant (Quviviq) is an orexin receptor antagonist indicated for the
treatment of adults with insomnia characterized by difficulty initiating and/or
maintaining sleep.
Quviviq is a new generation of insomnia treatment drugs, and its unique pharmacological effects provide a new option for improving sleep disorders. This article will introduce the clinical applic...
Quviviq is a novel dual orexin receptor antagonist that was approved by the US FDA in 2022 for the treatment of insomnia in adults. This article will systematically introduce the core information...